157 related articles for article (PubMed ID: 18815725)
1. Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan.
Mori M; Naruto T; Imagawa T; Murata T; Takei S; Tomiita M; Itoh Y; Fujikawa S; Yokota S
Mod Rheumatol; 2009; 19(1):1-11. PubMed ID: 18815725
[TBL] [Abstract][Full Text] [Related]
2. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
[TBL] [Abstract][Full Text] [Related]
4. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
Kostik MM; Gaidar EV; Hynnes AY; Dubko MF; Masalova VV; Snegireva LS; Chikova IA; Isupova EA; Nikitina TN; Serogodskaya ED; Kalashnikova OV; Ravelli A; Chasnyk VG
Clin Exp Rheumatol; 2016; 34(4):714-8. PubMed ID: 27385618
[TBL] [Abstract][Full Text] [Related]
6. Use of methotrexate in juvenile idiopathic arthritis.
Ramanan AV; Whitworth P; Baildam EM
Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting.
Ferrara G; Mastrangelo G; Barone P; La Torre F; Martino S; Pappagallo G; Ravelli A; Taddio A; Zulian F; Cimaz R;
Pediatr Rheumatol Online J; 2018 Jul; 16(1):46. PubMed ID: 29996864
[TBL] [Abstract][Full Text] [Related]
9. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
10. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
[TBL] [Abstract][Full Text] [Related]
11. Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis.
Pohjankoski H; Kautiainen H; Lauri JV; Puolakka K; Rantalaiho V
Clin Rheumatol; 2020 Jan; 39(1):263-268. PubMed ID: 31346886
[TBL] [Abstract][Full Text] [Related]
12. Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
Hsin YC; Zhuang LZ; Yeh KW; Chang CW; Horng JT; Huang JL
PLoS One; 2015; 10(6):e0128768. PubMed ID: 26047099
[TBL] [Abstract][Full Text] [Related]
13. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
Ćalasan MB; Wulffraat NM
Expert Rev Clin Immunol; 2014 Jul; 10(7):843-54. PubMed ID: 24857620
[TBL] [Abstract][Full Text] [Related]
15. Low-dose methotrexate treatment for oligoarticular juvenile idiopathic arthritis nonresponsive to intra-articular corticosteroids.
Brik R; Gepstein V; Berkovitz D
Clin Rheumatol; 2005 Nov; 24(6):612-4. PubMed ID: 15877178
[TBL] [Abstract][Full Text] [Related]
16. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
Roszkiewicz J; Smolewska E
Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate: new uses for an old drug.
Hashkes PJ; Becker ML; Cabral DA; Laxer RM; Paller AS; Rabinovich CE; Turner D; Zulian F
J Pediatr; 2014 Feb; 164(2):231-6. PubMed ID: 24286573
[No Abstract] [Full Text] [Related]
19. Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance.
Smits RM; Veldhuijzen DS; van Middendorp H; Hissink Muller PCE; Armbrust W; Legger E; Wulffraat NM; Evers AWM
Pediatr Rheumatol Online J; 2020 Feb; 18(1):12. PubMed ID: 32033577
[TBL] [Abstract][Full Text] [Related]
20. A case of juvenile idiopathic arthritis exhibiting repair of systemic bone erosion in response to continuation of MTX therapy after achievement of clinical remission.
Nakatani T; Maekawa T; Ishii S
Mod Rheumatol; 2011 Oct; 21(5):514-7. PubMed ID: 21331659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
